Le Lézard
Classified in: Health, Business, Covid-19 virus
Subjects: FOR, CFG

Prime Minister concludes productive G7 Leaders' meeting


OTTAWA, ON, Feb. 19, 2021 /CNW/ - The global COVID-19 pandemic has impacted the health and economic wellbeing of people both here in Canada, and around the world. To continue to keep our people safe and supported, and build back better in a way that creates jobs and economic growth, including through ambitious climate action, Canada will continue to work with our international partners to tackle the greatest challenges of our time.

The Prime Minister, Justin Trudeau, today participated in a virtual meeting of the G7 Leaders and announced new funding to help beat the virus globally.

Since February 2020, Canada has committed more than $2 billion towards the global COVID-19 response. Today, Canada will provide an additional $75 million to top-up our support to the Access to COVID-19 Tools (ACTAccelerator that develops and provides tests, treatments, and vaccines around the world ? because to defeat the virus at home, we have to defeat it everywhere.

The Prime Minister also welcomed new contributions from G7 Leaders to these global vaccination efforts, and reiterated Canada's shared commitment to cooperating on the COVID-19 response, and laying the foundation for a strong and sustainable economic recovery.

Working together with G7 partners will be vital to creating jobs and economic growth as we recover from the global pandemic. That includes building fairer trading systems, fighting climate change, and seizing the economic opportunities for clean growth. Today, the Prime Minister highlighted Canada's continued leadership and commitment to build a cleaner and more competitive world.

We must also create opportunity for those who have been disproportionately impacted by the pandemic, including women, racialized groups, and Indigenous peoples. The Prime Minister welcomed the United Kingdom's decision to convene a G7 Gender Equality Advisory Council ? a key legacy of the 2018 G7 Summit in Charlevoix ? to ensure gender equality is central to the work of the G7 this year.

Our work to build back better must also include a continued commitment to strengthen democracy and democratic institutions around the world. The Prime Minister, today, also stressed the global need to respect human rights and defend the rule of law, in order to prevent persecution and mistreatment around the world.

Only together can we tackle the current challenges we face. While we continue to do whatever it takes, for as long as it takes, to keep Canadians safe and supported during this crisis, we will also continue to work with our G7 counterparts to defeat the virus everywhere and build a more resilient future for everyone.

Quote

"Together, we can tackle the most pressing global challenges, and build a safer and more resilient future for everyone. Today's G7 meeting was an opportunity to address the health and economic impacts of the global COVID-19 pandemic and discuss other important issues, including the climate crisis. Canada looks forward to continuing these discussions and supporting the UK's ambitious agenda throughout their 2021 G7 Presidency."
?The Rt. Hon. Justin Trudeau, Prime Minister of Canada

Quick Facts

Related Product

Associated Links

This document is also available at https://pm.gc.ca/

SOURCE Prime Minister's Office


These press releases may also interest you

at 23:38
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

at 23:33
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

at 22:54
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

at 22:03
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

at 20:35
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

at 19:05
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: